Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-04-05
2010-11-02
Helms, Larry R. (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S387100
Reexamination Certificate
active
07824872
ABSTRACT:
An objective of the present invention is to provide methods of screening for novel compounds that exhibit anticancer activity. The screening methods of the present invention comprise using serine/threonine kinase Pim-1, or partial peptides or salts thereof.
REFERENCES:
patent: 5871960 (1999-02-01), Smith et al.
patent: 7268136 (2007-09-01), Green et al.
patent: 7318924 (2008-01-01), McKenzie et al.
patent: 2004/0146942 (2004-07-01), Weihe et al.
patent: WO 02/077033 (2002-10-01), None
patent: WO 02/093173 (2002-11-01), None
Mizuno et al. (BBRC vol. 281, pp. 663-669, 2001).
Wang et al. (Archives of Biochemistry and Biophysics, vol. 390, pp. 9-18, 2001).
Apantaku LM. Breast cancer diagnosis and screening, American Family Physician (2000). (Electronic version, downloaded from http://www.healthlibrary.com/doctors2/breastcancer2.html).
Martin et al (Journal of the National Cancer Institute, 92:1126-1135, 2000).
Whitmarsh et al. (Methods in Enzymology, vol. 332, pp. 319-336, 2001).
Luo, “Current research status of small molecular polypeptides antagonizing or mimicking cytokine activities,”Foreign Medical Science, 2002, 25(3):121-125 (English-language summary included).
Brown, “Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies,”Mol. Med. Today,2000, 61:157-162.
Brown and Giaccia, “The Unique Physiology of Solid Tumors: Opportunities (and Problems) for Cancer Therapy,”Cancer Res., 1998, 58:1408-1416.
Comerford et al., “Hypoxia-inducible Factor-1-dependent Regulation of the Multidrug Resistance (MDRI) Gene,”Cancer Res., 2002, 62:3387-3394.
Cuypers et al., “Murine Leukemia Virus-Induced T-Cell Lymphomagenesis: Integration of Proviruses in a Distinct Chromosomal Region,”Cell, 1984, 37:141-150.
Dhanasekaran et al., “Delineation of prognostic biomarkers in prostate cancer,”Nature, 2001, 412:822-826.
Luk et al., “Effect of Transient Hypoxia on Sensitivity to Doxorubicin in Human and Murine Cell Lines,”J. Natl. Cancer Inst., 1990, 82:684-692.
Möröy et al., “Expression of aPim-1transgene accelerates lymphoproliferation and inhibits apoptosis inlpr/lprmice,”Proc. Natl. Acad. Sci. USA, 1993, 90:10734-10738.
Niizeki et al., “Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells,”Br. J. Cancer, 2002, 86:1914-1919.
Sakata et al., “Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance,”Br. J. Cancer, 1991, 64:809-814.
Sanna and Rofstad, “Hypoxia-Induced Resistance to Doxorubicin and Methotrexate in Human Melanoma Cell Lines In Vitro,”Int. J. Cancer, 1994, 58:258-262.
Selten et al., “Proviral activation of the putative oncogenePim-1 in MuLV induced T-cell lymphomas,”EMBO J., 1985, 4(7):1793-1798.
Teh, “Pim-1 induced by hypoxia is involved in drug resistance and tumorigenesis of solid tumor cells,”Hokkaido Igaku Zasshi, 2004, 79:19-23, 25-26.
Teicher, “Hypoxia and drug resistance,”Cancer Metastasis Rev., 1994, 13:139-168.
Verbeek et al., “Mice Bearing the Eμ-mycand Eμ-pim-1 Transgenes Develop Pre-B-Cell Leukemia Prenatally,”Mol. Cell. Biol., 1991, 11(2):1176-1179.
Wang et al., “Pim-1: A serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis,”J. Vet. Sci., 2001, 2(3):167-179.
Zakut-Houri et al., “The cDNA sequence and gene analysis of the humanpimoncogene,”Gene, 1987, 54:105-111.
Chen Jian
Kobayashi Masanobu
Fish & Richardson P.C.
Helms Larry R.
Natarajan Meera
Theravalues Corporation
LandOfFree
Pharmaceutical agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4176205